Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Dr. Thomas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 1995 - 1998
San Antonio Uniformed Services Health Education ConsortiumResidency, Pediatrics, 1991 - 1994
Uconn School Of MedicineClass of 1992
Certifications & Licensure
TX State Medical License 1998 - 2026
MO State Medical License Active through 2013
Clinical Trials
- Arsenic Trioxide in Treating Patients With Refractory or Relapsed Chronic Lymphocytic Leukemia Start of enrollment: 2000 Jun 01
- Arsenic Trioxide in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Has Not Responded to Previous Treatment Start of enrollment: 2000 Jun 19
- Study of Intravenous BCX-1777 in Relapsed or Refractory Aggressive T-Cell Leukemias or Lymphomas Start of enrollment: 2001 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 11 citationsA phase I study of moxetumomab pasudotox in adults with relapsed or refractory B-cell acute lymphoblastic leukaemiaNicholas J. Short, Hagop M. Kantarjian, Elias Jabbour, Jorge E. Cortes, Deborah A. Thomas
British Journal of Haematology. 2018-08-01 - 75 citationsHyper-CVAD plus nelarabine in newly diagnosed adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma.Yasmin Abaza, Hagop M. Kantarjian, Stefan Faderl, Elias Jabbour, Nitin Jain
American Journal of Hematology. 2018-01-01 - 127 citationsSalvage Chemoimmunotherapy With Inotuzumab Ozogamicin Combined With Mini–Hyper-CVD for Patients With Relapsed or Refractory Philadelphia Chromosome–Negative Acute Lymp...Elias Jabbour, Farhad Ravandi, Partow Kebriaei, Xuelin Huang, Nicholas J. Short
JAMA Oncology. 2017-08-31
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
